Skip to content

Clinical Evaluation of Ayurvedic Formulations in OSMF.

Phytoconstituent Docking, In-vitro Fibroblast Modulation, and Clinical Evaluation of Ayurvedic Formulations in OSMF. - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084682
Enrollment
99
Registered
2025-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K135- Oral submucous fibrosis

Interventions

None listed

Sponsors

Dr Sarika Palve
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining of reduced mouth opening, stiffness of oral mucosa, repeated vesicular eruption and ulceration in mouth, burning sensation in mouth, intolerance to eat hot and spicy foods etc.,

Exclusion criteria

Exclusion criteria: patients below 18 years and above 60 years, Extensive fibrosis of Oral Mucosa, Inter incisor distance of less than 15 mm, Oral Lichen Planus

Design outcomes

Primary

MeasureTime frame
improvement in mouth openingTimepoint: Baseline, 3 months

Secondary

MeasureTime frame
Reduction in pain and discomfort during mastication. reduction in burning sensationTimepoint: 3 months

Countries

India

Contacts

Public ContactDrsarika Palve

Bhausaheb Mulak Ayurved College & RH butibori Nagpur

dhpsarika@gmail.com8983421386

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026